79 related articles for article (PubMed ID: 22014059)
1. Unusual c-KIT (+) squamous cell carcinoma of uterine cervix showing remarkable platelet-derived growth factor receptor, alpha subunit expression, but no activating mutation.
Han CP; Chen CK; Lin CK; Wang PH; Chiang H
Histopathology; 2011 Oct; 59(4):788-90. PubMed ID: 22014059
[No Abstract] [Full Text] [Related]
2. Expression and mutational analyses of KIT and PDGFR-alpha in sarcomatoid renal cell carcinoma.
Petit A; Castillo M; Gaspa A; Colomer D; Garcia de Albéniz X; Moreno C; Camós M; Mellado B; Mallofré C
Histopathology; 2009 Aug; 55(2):230-2. PubMed ID: 19694830
[No Abstract] [Full Text] [Related]
3. Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers.
Wilczynski SP; Chen YY; Chen W; Howell SB; Shively JE; Alberts DS
Hum Pathol; 2005 Mar; 36(3):242-9. PubMed ID: 15791568
[TBL] [Abstract][Full Text] [Related]
4. Unusual c-KIT+ squamous cell carcinoma of the uterine cervix showing paradoxical hypermethylation of the c-KIT proto-oncogene.
Chao WR; Lin WL; Chen CK; Han LM; Lin JC; Han CP
Eur J Obstet Gynecol Reprod Biol; 2015 Jan; 184():130-1. PubMed ID: 25524714
[No Abstract] [Full Text] [Related]
5. A promising hypothesis of c-KIT methylation/ expression paradox in c-KIT (+) squamous cell carcinoma of uterine cervix ----- CTCF transcriptional repressor regulates c-KIT proto-oncogene expression.
Chang SW; Chao WR; Ruan A; Wang PH; Lin JC; Han CP
Diagn Pathol; 2015 Nov; 10():207. PubMed ID: 26607501
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of c-KIT (CD117) occurs infrequently in squamous cell carcinoma of the uterine cervix.
Han CP; Lin WL; Wang PH; Yang SF; Lewis JS; Chen CK; Ruan A; Kuo JF; Lee MY; Chiang H
Histopathology; 2011 May; 58(6):988-90. PubMed ID: 21585433
[No Abstract] [Full Text] [Related]
7. High-resolution melting amplicon analysis as a method to detect c-kit and platelet-derived growth factor receptor alpha activating mutations in gastrointestinal stromal tumors.
Holden JA; Willmore-Payne C; Coppola D; Garrett CR; Layfield LJ
Am J Clin Pathol; 2007 Aug; 128(2):230-8. PubMed ID: 17638656
[TBL] [Abstract][Full Text] [Related]
8. Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomas.
Tamborini E; Miselli F; Negri T; Lagonigro MS; Staurengo S; Dagrada GP; Stacchiotti S; Pastore E; Gronchi A; Perrone F; Carbone A; Pierotti MA; Casali PG; Pilotti S
Clin Cancer Res; 2006 Dec; 12(23):6920-8. PubMed ID: 17145809
[TBL] [Abstract][Full Text] [Related]
9. KIT-positive primary small cell carcinoma of the endometrium: a case report with immunohistochemical and molecular genetic analysis of KIT and PDGFRA genes.
Terada T
Arch Gynecol Obstet; 2010 Oct; 282(4):413-6. PubMed ID: 20035340
[TBL] [Abstract][Full Text] [Related]
10. Response of a KIT-positive extra-abdominal fibromatosis to imatinib mesylate and KIT genetic analysis.
Gonçalves A; Monges G; Yang Y; Palmerini F; Dubreuil P; Noguchi T; Jacquemier J; Di Stefano D; Delpero JR; Sobol H; Bertucci F
J Natl Cancer Inst; 2006 Apr; 98(8):562-3. PubMed ID: 16622127
[No Abstract] [Full Text] [Related]
11. KIT activation in uterine cervix adenosquamous carcinomas by KIT/SCF autocrine/paracrine stimulation loops.
Martinho O; Gonçalves A; Moreira MA; Ribeiro LF; Queiroz GS; Schmitt FC; Reis RM; Longatto-Filho A
Gynecol Oncol; 2008 Nov; 111(2):350-5. PubMed ID: 18708242
[TBL] [Abstract][Full Text] [Related]
12. The expression of type I growth factor receptors in the squamous neoplastic changes of uterine cervix.
Chang JL; Tsao YP; Liu DW; Han CP; Lee WH; Chen SL
Gynecol Oncol; 1999 Apr; 73(1):62-71. PubMed ID: 10094882
[TBL] [Abstract][Full Text] [Related]
13. Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas.
Do I; Araujo ES; Kalil RK; Bacchini P; Bertoni F; Unni KK; Park YK
Pathol Res Pract; 2007; 203(3):127-34. PubMed ID: 17298867
[TBL] [Abstract][Full Text] [Related]
14. Comparison of gene expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.
Contag SA; Gostout BS; Clayton AC; Dixon MH; McGovern RM; Calhoun ES
Gynecol Oncol; 2004 Dec; 95(3):610-7. PubMed ID: 15581972
[TBL] [Abstract][Full Text] [Related]
15. Expression of BDNF, TrkB, and p53 in early-stage squamous cell carcinoma of the uterine cervix.
Moon A; Won KY; Lee JY; Kang I; Lee SK; Lee J
Pathology; 2011 Aug; 43(5):453-8. PubMed ID: 21670725
[TBL] [Abstract][Full Text] [Related]
16. Expression of c-kit and platelet-derived growth factor receptors in ovarian granulosa cell tumors.
Rocconi RP; Matthews KS; Kimball KJ; Conner MG; Baker AC; Barnes MN
Reprod Sci; 2008 Sep; 15(7):673-7. PubMed ID: 18492696
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal stromal tumor in Brazil: clinicopathology, immunohistochemistry, and molecular genetics of 513 cases.
Lopes LF; Ojopi EB; Bacchi CE
Pathol Int; 2008 Jun; 58(6):344-52. PubMed ID: 18477213
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic/nuclear expression without mutation of exon 3 of the beta-catenin gene is frequent in the development of the neoplasm of the uterine cervix.
Shinohara A; Yokoyama Y; Wan X; Takahashi Y; Mori Y; Takami T; Shimokawa K; Tamaya T
Gynecol Oncol; 2001 Sep; 82(3):450-5. PubMed ID: 11520139
[TBL] [Abstract][Full Text] [Related]
19. KIT and platelet-derived growth factor receptor alpha tyrosine kinase gene mutations and KIT amplifications in human solid tumors.
Sihto H; Sarlomo-Rikala M; Tynninen O; Tanner M; Andersson LC; Franssila K; Nupponen NN; Joensuu H
J Clin Oncol; 2005 Jan; 23(1):49-57. PubMed ID: 15545668
[TBL] [Abstract][Full Text] [Related]
20. KIT expression in normal and neoplastic renal tissues: immunohistochemical and molecular genetic analysis.
Kato N; Honma K; Hojo H; Sasou S; Matsuzaki O; Motoyama T
Pathol Int; 2005 Aug; 55(8):479-83. PubMed ID: 15998375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
